Rapastinel (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist.
CAT No: R0954
CAS No:117928-94-6
Synonyms/Alias:Rapastinel;117928-94-6;GLYX 13;GLYX-13;GLYX13;TPPT-amide;Rapastinelum;GLYX-13 peptide;UNII-6A1X56B95E;L-Threoninamide, L-threonyl-L-prolyl-L-prolyl-;Rapastinel [USAN:INN];GLYX-13 trifluoroacetate;RAPASTINEL [INN];RAPASTINEL [USAN];RAPASTINEL [WHO-DD];6A1X56B95E;(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide;(S)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-((S)-1-((2S,3R)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide;L-THREONYL-L-PROLYL-L-PROLYL-L-THREONINAMIDE;(2S,3R)-2-(((2S)-1-((2S)-1-((2S,3R)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidin-2-yl)formamido)-3-hydroxybutanamide;(2S,3R)-2-{[(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamide;GLYX13;Rapastinel;Rapastinel (GLYX-13);Rapastinel(GLYX-13)?;TPPT-amide trifluoroacetate;SCHEMBL1668190;CHEMBL3544917;EX-A794;GIBQQARAXHVEGD-BSOLPCOYSA-N;DTXSID501030481;MFCD12912477;MFCD20527320;s6907;AKOS024457610;CS-5507;DB11801;NCGC00485669-01;AC-32874;AS-55920;HY-16728;NS00072942;Q5513673;BRD-K02206208-001-01-4;L-Threonyl-L-prolyl-L-prolyl-L-threoninamide trifluoroacetate; Thr-Pro-Pro-Thr-NH2 trifluoroacetate;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More